Inicio › Cáncer (todos los tipos) › Nueva Jersey
Ensayos clínicos de Cáncer (todos los tipos) en Nueva Jersey
61 estudios sobre Cáncer (todos los tipos) buscan participantes en Nueva Jersey.
Ciudades en Nueva Jersey
- Edison33 estudios
- Clifton13 estudios
- Camden7 estudios
- Newark7 estudios
- Trenton4 estudios
- Brick3 estudios
- Paterson3 estudios
Texto oficial del estudio (inglés)
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009), Hackensack
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT06818643Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors
- Rutgers Cancer Institute, New Brunswick
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06844981Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooper Hospital University Medical Center, Camden
- The Cancer Institute of New Jersey Hamilton, Hamilton
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Jersey Shore University Medical Center | Hackensack, Neptune City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07195591Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07454330Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- MD Anderson Cancer Center at Cooper, Camden
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- START Astera, LLC, East Brunswick
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07540572A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Capital Health - Hematology Oncology Specialists, Pennington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06901531A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- START New Jersey, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The Valley Hospital, Inc., Paramus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Hackensack University Medical Center, Hackensack
- Morristown Memorial Hosp, Morristown
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Rutgers Cancer Institute of New Jersey ( Site 1100), New Brunswick
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07209111Visugromab in Cachexia International Trial
- Astera Cancer Care, East Brunswick
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07112196A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07247110A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Rutgers Cancer Institute of New Jersey ( Site 4008), New Brunswick
ReclutandoFase 1/2
1 Month – 17 Years · Todos los sexos · Actualizado el 30 oct 2026 · NCT07630974A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT07094204Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
- Cooper University Hospital, Camden
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Mujeres · Actualizado el 22 oct 2026 · NCT02749474A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Atlantic Health System / Morristown Medical Center, Morristown
- Jack & Sheryl Morris Cancer Center, New Brunswick
- Rutgers Cancer Institute, New Brunswick
- y 3 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT05382559A Study of Music Therapy for Anxiety in People With Cancer
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT07845422A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0105), Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07030712A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0021), Hackensack
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT06979596A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Rutgers Cancer Institute of New Jersey ( Site 3008), New Brunswick
ReclutandoFase 1/2
1 Month – 17 Years · Todos los sexos · Actualizado el 6 oct 2026 · NCT06941272A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Astera Cancer Care /ID# 277570, East Brunswick
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07155187A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Holy Name Medical Center /ID# 279017, Teaneck
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07192471uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Rutgers, New Brunswick
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- ProCure Proton Therapy Center, Somerset
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT01255748A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07365241Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoEstudio observacional
Edades de 21 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT01742143A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Rutgers Cancer Institute, New Brunswick
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06253871Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hunterdon Medical Center, Flemington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07075185Project: Every Child for Younger Patients With Cancer
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Jersey Shore Medical Center, Neptune City
- y 4 más
ReclutandoEstudio observacional
Hasta los 25 · Todos los sexos · Actualizado el 25 ago 2026 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Robert Wood Johnson University Hospital, New Brunswick
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT05335928Acupuncture for People Experiencing Period Loss Due to Chemotherapy
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
ReclutandoFase 2
Edades de 15 a 40 · Mujeres · Actualizado el 17 ago 2026 · NCT06915116A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT05859074A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT06764771Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT05533697Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07216443De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.